INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

68,022 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
GP
Greenleaf PeterDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$2,318
85 sh
Jul 2, 2026Jul 7, 2026
Page 558 of 1701
← PrevNext →
traded Jul 2, 2026
+5d
SEC Form 4

Evidence

17
FM
Friedberg Ezra MDirector
PTHSPelthos Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$656
24 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

16
VA
Verma AbhimanyuChief Technology Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$27K
5,285 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
840 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$1,445
333 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
BI
Barchas IsaacDirector
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$409K
16.9K sh
Jul 7, 2026Jul 7, 2026
traded Jul 7, 2026
+0dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
280 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
MK
Malkoski Kristine KayPresident, Learning & Dev.
NWLNEWELL BRANDS INC.
Tax withholding
F$197K
33.7K sh
Jul 5, 2026Jul 7, 2026
traded Jul 5, 2026
+2dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$228K
1,105 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
720 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
320 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Executive Chairman
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$118K
22.5K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
PS
Perry Jennifer ScottChief Operating Officer
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale · 10b5-1 plan
SELL$185
43 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$97K
480 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$130K
637 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
1,058 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$177K
880 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

16
MR
Muken RossDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$51K
9,838 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

15
SA
Samuels Michele AnnetteDirector
HBNCHORIZON BANCORP INC /IN/
Grant or award
A$6,667
332 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

15
PC
Pendarvis ChristianeDirector
SHAKShake Shack Inc.
Grant or award
A—
2,480 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

15
HW
Hershman Lisa W.Director
ECHOEchoStar CORP
Option exercise
M—
10.0K sh
Jul 1, 2026Jul 7, 2026
traded Jul 1, 2026
+6dSEC Form 4

Evidence

15
HH
Harris Isaac HosojiroDirector
LITELumentum Holdings Inc.
Grant or award
A—
258 sh
May 29, 2026Jul 7, 2026
traded May 29, 2026
+39dSEC Form 4

Evidence

15
SR
Schlossman RobertChief Legal Officer
ZSZscaler, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
122 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

15
GK
George Christopher KileEVP & CFO
WTTRSelect Water Solutions, Inc.
Tax withholding
F$13K
730 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

15
SJ
Spencer JohnChief Financial Officer
OGENORAGENICS INC
Grant or award
A—
55.9K sh
Jul 1, 2026Jul 7, 2026
traded Jul 1, 2026
+6dSEC Form 4

Evidence

15
HK
Hettrich KevinCHIEF FINANCIAL OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$71K
9,800 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

14
PR
Potts James REVP Gen Counsel & Secretary
BBSIBARRETT BUSINESS SERVICES INC
Open-market sale · 10b5-1 plan
SELL$68K
1,802 sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

14
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
25.0K sh
Jul 2, 2026Jul 7, 2026
traded Jul 2, 2026
+5dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
80 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
PF
Posthauer Robert F.President, Home & Com. - Com.
NWLNEWELL BRANDS INC.
Tax withholding
F$31K
5,242 sh
Jul 5, 2026Jul 7, 2026
traded Jul 5, 2026
+2dSEC Form 4

Evidence

13
KP
Kellenberger PaulDirector, Chief Executive Officer
ZSPCzSpace, Inc.
Tax withholding
F$297
1,443 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
DE
DeOliveira ErickChief Financial Officer
ZSPCzSpace, Inc.
Tax withholding
F$163
792 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$7,839
40 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$8,419
1,592 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$8,370
40 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
7,393 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$148K
17.4K sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
80 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$38K
7,393 sh
Jul 6, 2026Jul 7, 2026
traded Jul 6, 2026
+1dSEC Form 4

Evidence

13
HA
Huet Melanie ArlenePresident, Home & Com - Home
NWLNEWELL BRANDS INC.
Tax withholding
F$30K
5,146 sh
Jul 5, 2026Jul 7, 2026
traded Jul 5, 2026
+2dSEC Form 4

Evidence